Amarin (AMRN) Announces FDA Acceptance of Filing for NDA on AMR101; David Feigal to Resign from Board
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Amarin (Nasdaq: AMRN) announces FDA acceptance of its filing for an NDA on AMR101.
Also announced the resignation of David Feigal from its Board of Directors.
Also announced the resignation of David Feigal from its Board of Directors.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight
- Boeing names Ryan Shedd as new SVP and controller
- WISeKey names Alexander Hirsch as group chief marketing officer
Create E-mail Alert Related Categories
FDA, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
